Founder and Principal
Syner-G Biopharma Group
Framingham, Massachusetts
Prabu Nambiar is the Founder and Principal at Syner-G Bio Pharma Group, LLC that provides drug development consulting services to pharma and biotech companies in the areas of Chemistry, Manufacturing and Controls, Toxicology/DMPK, Regulatory Affairs and Quality/GxP Compliance.
Prabu got his M.Sc. in chemistry from India, and Ph.D. in Organic Chemistry from Oregon State University. He did his post-doctoral training at Brown University and completed the executive MBA program at Boston University.
Prior to starting Syner-G, Prabu was the VP and Head of CMC Regulatory Affairs at Vertex Pharmaceuticals. He also held positions of increasing responsibilities at Cubist, Wyeth, Sepracor, and BMS. Prabu is a member of the AAPS over 25 years and played active roles such as the Chair of the Regulatory Science section and member of Finance Committee. He served two terms in the Unites States Pharmacopeia (USP) Physical Analysis Expert Committee.
Since the founding of Syner-G in 2007, it grew steadily over the years to a 200+ people team and currently they support over 100+ companies. In 2020, they signed a partnership with Riverside Partners, a PE firm based in Boston. Syner-G has been recognized as one of top pharma service provider by various organizations.
Disclosure information not submitted.
How to Negotiate Contracts Like a Pro
Wednesday, October 23, 2024
10:30 AM – 11:30 AM MT